Celldex (NASDAQ:CLDX) announced that its management will participate in three upcoming investor conferences in February and March 2026. These include the Guggenheim Emerging Outlook: Biotech Summit, TD Cowen Health Care Conference, and Leerink Global Healthcare Conference, all of which will feature live webcasts and 90-day replays for interested investors. The company will use these platforms to engage with investors regarding its advancements in immunology and antibody-based therapies.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Biotech Celldex to field investor questions at 3 conferences
Celldex (NASDAQ:CLDX) announced that its management will participate in three upcoming investor conferences in February and March 2026. These include the Guggenheim Emerging Outlook: Biotech Summit, TD Cowen Health Care Conference, and Leerink Global Healthcare Conference, all of which will feature live webcasts and 90-day replays for interested investors. The company will use these platforms to engage with investors regarding its advancements in immunology and antibody-based therapies.